Vanja Zeremski

6PUBLICATIONS
23CO-AUTHORS
Solid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 26, 2026
Response-adapted consolidation and salvage strategies in secondary central nervous system lymphoma: Insights from a multicentre cohort.

|Feb 07, 2025
Efficacy and safety of first-line high-dose cytarabine in patients with primary CNS lymphoma ineligible for high-dose methotrexate: A case series.

Vanja Zeremski, Tobias Ronny Haage, Dimitrios Mougiakakos

|Jan 02, 2024
Relevance of different prognostic scores in primary CNS lymphoma in the era of intensified treatment regimens: A retrospective, multicenter analysis of 174 patients.

Vanja Zeremski, Louisa Adolph, Sina Beer

|Nov 10, 2019
Is bendamustine-rituximab a reasonable treatment in selected older patients with diffuse large B cell lymphoma? Results from a multicentre, retrospective study.

Vanja Zeremski, Kathleen Jentsch-Ullrich, Christoph Kahl

Pageof 1

Frequent Collaborators

2 joint publications

Dimitrios Mougiakakos

1 joint publications

Enrico Schalk

1 joint publications

Ellen D McPhail

1 joint publications

Thomas M Habermann